The stock market rebounded on Wednesday with the small-caps leading the charge higher and the blue-chips struggling. Some of the strength came after a few Federal Reserve officials helped ease worries about higher inflation.A dip in bond yields continues to be positive for Technology as the 10-year Treasury note is pushing two-week lows. Key resistance levels remain in play with Wall Street...
Continue reading >>Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN...
Continue reading >>The stock market rebounded on Wednesday with the small-caps leading the charge higher and the blue-chips struggling. Some of the strength came after a few Federal Reserve officials helped ease worries about higher inflation.A dip in bond yields continues to be positive for Technology as the 10-year Treasury note is pushing two-week lows. Key resistance levels remain in play with Wall Street...
Continue reading >>...
Continue reading >>The stock market traded on both sides of the ledger on Tuesday following a disappointing update on new home sales which declined 5.9% to a 863,000 rate in April. Other housing news was mostly positive as the FHFA home price index rose 1.4% to 324.9 while the S&P Case-Shiller 20-city home price index gained 2.2% to 251.6. The slightly lower close was a disappointment but remains a bullish...
Continue reading >>Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN...
Continue reading >>